Monte Rosa Therapeutics
GLUE
NASDAQ
IPO2021
about GLUE
Monte Rosa Therapeutics is a biotech company focused on precision medicine, particularly in immuno-oncology, using advanced computational methods like machine learning and genomics to identify novel cancer targets and develop innovative antibody-based therapeutic treatments.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $7.22 | $7.40 | $6.06 | $297.06M | 28.79M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$0.00 | n/a | 24.27 | -67.06% | -53.01% | 0% |